Sophorus species for chronic hepatitis B virus infection

  • Protocol
  • Intervention

Authors

  • Yu Feng Wu,

    1. Beijing University of Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing, China
    Search for more papers by this author
  • Xing Liao,

    1. Beijing University of Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing, China
    Search for more papers by this author
  • Jian Ping Liu

    Corresponding author
    1. b) National Research Centre in Complementary and Alternative Medicine (NAFKAM), Tromsø, Norway, c) Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Copenhagen, Denmark, a) Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China, Beijing, China
    • Jian Ping Liu, a) Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China, b) National Research Centre in Complementary and Alternative Medicine (NAFKAM), Tromsø, Norway, c) Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Copenhagen, Denmark, Beijing, 100029, China. jianping_l@hotmail.com. jianping@fagmed.uit.no.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of extracts of the Chinese herbs belonging to the Sophorus species, as matrine and oxymatrine, in patients with chronic hepatitis B.